PAMU
ANIP icon

Pictet Asset Management (UK)’s ANI Pharmaceuticals ANIP Stock Holding History

Pictet Asset Management (UK)’s Portfolio ANIP Stock Details ANIP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-51,553
Closed -$1.67M – 1563
2020
Q2 		$1.67M Sell
51,553
-5,700
-10% -$204K ﹤0.01% 879
2020
Q1 		$2.33M Buy
57,253
+41,200
+257% +$2.19M 0.01% 829
2019
Q4 		$990K Sell
16,053
-1,500
-9% -$99.4K ﹤0.01% 988
2019
Q3 		$1.28M Buy
17,553
+1,300
+8% +$97.3K ﹤0.01% 902
2019
Q2 		$1.34M Buy
+16,253
New +$1.16M ﹤0.01% 899

Other funds holding ANIP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
TSW
Thompson Siegel & Walmsley Richmond, Virginia $5.57B AUM 9.46% 1-Year Est. Return
ICOM
Investment Counselors of Maryland Baltimore, Maryland $4.37B AUM 76.25% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
GACM
Global Alpha Capital Management Montreal, Quebec, Canada $1.67B AUM 35.09% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Pictet Asset Management (UK)'s ANIP Position: Q3 2020 in Review

Pictet Asset Management (UK) sold out of ANI Pharmaceuticals (ANIP) in Q3 2020, closing a stake of 51,553 shares — an estimated $1.67M sold.

Pictet Asset Management (UK) first reported a position in ANIP in Q2 2019 and held it in 5 quarters. The position peaked at $2.33M in Q1 2020. 116 funds tracked by Wall St. Rank hold ANIP as of Q3 2020.

  • Pictet Asset Management (UK) reported no remaining ANI Pharmaceuticals position as of Q3 2020 after selling out during the quarter.
  • Pictet Asset Management (UK) sold 51,553 ANI Pharmaceuticals shares in Q3 2020, an estimated $1.67M.
  • Pictet Asset Management (UK) first reported a position in ANI Pharmaceuticals in Q2 2019 and held it in 5 quarters.
  • Pictet Asset Management (UK)'s ANI Pharmaceuticals position peaked at $2.33M in Q1 2020.
  • 116 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q3 2020.

Based on Pictet Asset Management (UK)'s 13F filing for Q3 2020, filed 12 Nov 2020.